SCHEMBL6711069

SCHEMBL6711069

CN(C)C(CCCC=O)Cc1cccc2ccccc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 3/20 0.50
CYP2D6 P10635 3/20 0.43
CYP1A2 P05177 2/20 0.43
CYP2C19 P33261 2/20 0.43
MMP9 P14780 1/20 0.40
CTNNB1 P35222 1/20 0.40
SIGMAR1 Q99720 3/20 0.38
NR1I2 O75469 2/20 0.36
SLC6A2 P23975 2/20 0.36
HTR2A P28223 2/20 0.36
SLC6A4 P31645 2/20 0.36
KCNH2 Q12809 2/20 0.36
LMNA P02545 2/20 0.36
KMT2A Q03164 2/20 0.36
DRD2 P14416 1/20 0.36
ADRA2C P18825 1/20 0.36
CNR1 P21554 1/20 0.36
ADRA1A P35348 1/20 0.36
OPRK1 P41145 1/20 0.36
SLC6A3 Q01959 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6711071 0.82 CYP2D6 (0.46) OPRM1CYP2D6CYP1A2CYP2C19MMP9
SCHEMBL8326605 0.74 CYP2D6 (0.50) OPRM1CYP2D6CYP1A2CYP2C19MMP9
SCHEMBL18602117 0.74 CYP1A2 (0.50) OPRM1CYP2D6CYP1A2CYP2C19MMP9
SCHEMBL143128 0.73 MTNR1A (0.47) CYP2D6CYP1A2CYP2C19SIGMAR1
SCHEMBL3225216 0.71 MTNR1A (0.45) CYP2D6CYP1A2CYP2C19SIGMAR1
SCHEMBL7302653 0.70 HTR1B (0.43) CYP2D6CYP1A2CYP2C19MMP9CTNNB1
SCHEMBL3244852 0.70 MTNR1A (0.44) CYP1A2CYP2C19SIGMAR1
SCHEMBL143458 0.69 MTNR1A (0.49) CYP2D6CYP1A2CYP2C19KMT2AMEN1
SCHEMBL9666926 0.69 CYP1A2 (0.47) OPRM1CYP2D6CYP1A2CYP2C19MMP9
Pentanal SCHEMBL8039271 0.69 CYP2D6 (0.47) CYP2D6CYP1A2CYP2C19SIGMAR1NR1I2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1392315-A1 METHODS OF TREATING ALZHEIMER'S DISEASE Elan Pharmaceuticals, Inc. (US) 2004-03-03 EP disclosed
WO-2002100410-A1 METHODS OF TREATING ALZHEIMER'S DISEASE ELAN PHARMACEUTICALS, INC. (US) 2002-12-19 WO disclosed